[1] LLOYD-PRICE J,ABU-ALI G,HUTTENHOWER C.The healthy human microbiome[J].Genome Med,2016, 8(1):51.
[2] HOYLES L,MCCARTNEY A L,NEVE H,et al.Characterization of virus-like particles associated with the human faecal and caecal microbiota[J].Res Microbiol,2014,165(10):803-812.
[3] EDWARDS R A,ROHWER F.Viral metagenomics[J].Nat Rev Microbiol,2005,3(6):504-510.
[4] MINOT S,SINHA R,CHEN J,et al.The human gut virome:inter-individual variation and dynamic response to diet[J]. Genome Res,2011,21(10):1616-1625.
[5] REYES A,HAYNES M,HANSON N,et al.Viruses in the faecal microbiota of monozygotic twins and their mothers[J].Nature,2010,466(7304):334-338.
[6] WEINBAUER M G.Ecology of prokaryotic viruses[J].FEMS Microbiol Rev,2004,28(2):127-181.
[7] BRÜSSOW H,CANCHAYA C,CANCHAYA W D.Phages and the evolution of bacterial pathogens:from genomic rearrangements to lysogenic conversion[J].Microbiol Mol Biol Rev,2004,68(3):560-602.
[8] MIRZAEI M K,MAURICE C F.Ménage à trois in the human gut:interactions between host,bacteria and phages[J].Nat Rev Microbiol,2017,15(7):397-408.
[9] REYES A,BLANTON L V,CAO S,et al.Gut DNA viromes of Malawian twins discordant for severe acute malnutrition[J].Proc Natl Acad Sci U S A,2015,112(38):11941-11946.
[10] NORMAN J M,HANDLEY S A,BALDRIDGE M T,et al.Disease-specific alterations in the enteric virome in inflammatory bowel disease[J].Cell,2015,160(3):447-460.
[11] KIM M S,BAE J W.Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice[J].Environ Microbiol,2016,18(5):1498-1510.
[12] KRISHNAMURTHY S R,JANOWSKI A B,ZHAO G Y,et al.Hyperexpansion of RNA bacteriophage diversity[J].PLoS Biol,2016,14(3):e1002409.
[13] HAVELAAR A H,FURUSE K,HOGEBOOM W M.Bacteriophages and indicator bacteria in human and animal faeces[J].J Appl Bacteriol,1986,60(3):255-262.
[14] LOOFT T,ALLEN H K,CANTAREL B L,et al.Bacteria,phages and pigs:the effects of in-feed antibiotics on the microbiome at different gut locations[J].ISME J,2014,8(8):1566-1576.
[15] ZOETENDAL E G,RAES J,VAN DEN BOGERT B,et al.The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates[J].ISME J,2012,6(7):1415-1426.
[16] SHARON I,MOROWITZ M J,THOMAS B C,et al.Time series community genomics analysis reveals rapid shifts in bacterial species,strains,and phage during infant gut colonization[J].Genome Res,2013,23(1):111-120.
[17] KOENIG J E,SPOR A,SCALFONE N,et al.Succession of microbial consortia in the developing infant gut microbiome[J].Proc Natl Acad Sci U S A,2011,108(S1):4578-4585.
[18] LIM E S,ZHOU Y J,ZHAO G Y,et al.Early life dynamics of the human gut virome and bacterial microbiome in infants[J].Nat Med,2015,21(10):1228-1234.
[19] THINGSTAD T F.Elements of a theory for the mechanisms controlling abundance,diversity,and biogeochemical role of lytic bacterial viruses in aquatic systems[J].Limnol Oceanogr,2000,45(6):1320-1328.
[20] MAHANA D,TRENT C M,KURTZ Z D,et al.Antibiotic perturbation of the murine gut microbiome enhances the adiposity,insulin resistance,and liver disease associated with high-fat diet[J].Genome Med,2016,8(1):48.
[21] CHARBONNEAU M R,O'DONNELL D,BLANTON L V,et al.Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition[J].Cell,2016,164(5):859-871.
[22] VAN HOUTE S,BUCKLING A,WESTRA E R.Evolutionary ecology of prokaryotic immune mechanisms[J].Microbiol Mol Biol Rev,2016,80(3):745-763.
[23] SAMSON J E,MAGADÁN A H,SABRI M,et al.Revenge of the phages:defeating bacterial defences[J].Nat Rev Microbiol,2013,11(10):675-687.
[24] BORGES A L,ZHANG J Y,ROLLINS M F,et al.Bacteriophage cooperation suppresses CRISPR-Cas3 and Cas9 immunity[J].Cell,2018,174(4):917-925.
[25] BARR J J,AURO R,FURLAN M,et al.Bacteriophage adhering to mucus provide a non-host-derived immunity[J].Proc Natl Acad Sci U S A,2013,110(26):10771-10776.
[26] BARR J J,AURO R,SAM-SOON N,et al.Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters[J].Proc Natl Acad Sci U S A,2015,112(44):13675-13680.
[27] BREITBART M,ROHWER F.Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing[J].Biotechniques,2005,39(5):729-736.
[28] MANKIEWICZ E,LⅡVAK M.Mycobacteriophages isolated from human sources[J].Nature,1967, 216(5114):485-486.
[29] MOUSTAFA A,XIE C,KIRKNESS E,et al.The blood DNA virome in 8000 humans[J].PLoS Pathog,2017, 13(3):e1006292.
[30] HAMZEH-MIVEHROUD M,MAHMOUDPOUR A,REZAZADEH H,et al.Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier[J].Eur J Pharm Biopharm, 2008, 70(2):577-581.
[31] HILDEBRAND G J,WOLOCHOW H.Translocation of bacteriophage across the intestinal wall of the rat[J]. Proc Soc Exp Biol Med,1962,109:183-185.
[32] WEBER-DABROWSKA B,DABROWSKI M,SLOPEK S.Studies on bacteriophage penetration in patients subjected to phage therapy[J].Arch Immunol Ther Exp,1987,35(5):563-568.
[33] NGUYEN S,BAKER K,PADMAN B S,et al.Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers[J].mBio,2017,8(6):e01874.
[34] HANDLEY S A,THACKRAY L B,ZHAO G Y,et al.Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome[J].Cell,2012,151(2):253-266.
[35] HSIA R C,OHAYON H,GOUNON P,et al.Phage infection of the obligate intracellular bacterium,Chlamydia psittaci strain Guinea pig inclusion conjunctivitis[J].Microb Infect,2000,2(7):761-772.
[36] PRANJOL M Z I,HAJITOU A.Bacteriophage-derived vectors for targeted cancer gene therapy[J].Viruses, 2015,7(1):268-284.
[37] ARONOW R,DANON D,SHAHAR A,et al.Electron microscopy of in vitro endocytosis of T2 phage by cells from rabbit peritoneal exudate[J].J Exp Med,1964,120(5):943-954.
[38] ZHANG L L,SUN L C,WEI R C,et al.Intracellular Staphylococcus aureus control by virulent bacteriophages within MAC-T bovine mammary epithelial cells[J].Antimicrob Agents Chemother,2017,61(2):e01990-16.
[39] UHR J W,FINKELSTEIN M S,BAUMANN J B.Antibody formation.Ⅲ.The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs[J].J Exp Med,1962,115:655-670.
[40] UHR J W,DANCIS J,FRANKLIN E C,et al.The antibody response to bacteriophage φX 174 in newborn premature infants[J].J Clin Invest,1962,41(7):1509-1513.
[41] DBROWSKA K,MIERNIKIEWICZ P,PIOTROWICZ A,et al.Immunogenicity studies of proteins forming the T4 phage head surface[J].J Virol,2014,88(21):12551-12557.
[42] MAJEWSKA J,BETA W,LECION D,et al.Oral application of T4 phage induces weak antibody production in the gut and in the blood[J].Viruses,2015,7(8):4783-4799.
[43] GÓRSKI A,KNIOTEK M,PERKOWSKA-PTASINSKA A,et al.Bacteriophages and transplantation tolerance[J].Trans Proc,2006,38(1):331-333.
[44] GÓRSKI A,WANA E,DBROWSKA B W,et al.Bacteriophage translocation[J].FEMS Immunol Med Microbiol, 2006,46(3):313-319.
[45] MIERNIKIEWICZ P,KLOPOT A,SOLUCH R,et al.T4 phage tail adhesin Gp12 counteracts LPS-induced inflammation in vivo[J].Front Microbiol,2016,7:1112.
[46] ZIMECKI M,ARTYM J,KOCIEBA M,et al.Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus[J].BMC Microbiol,2009,9(1):169.
[47] CHADHA P,KATARE O P,CHHIBBER S.Liposome loaded phage cocktail:enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections[J].Burns,2017,43(7):1532-1543.
[48] MANRIQUE P,BOLDUC B,WALK S T,et al.Healthy human gut phageome[J].Proc Natl Acad Sci U S A,2016,113(37):10400-10405.
[49] DUTILH B E,CASSMAN N,MCNAIR K,et al.A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes[J].Nat Commun,2014,5:4498.
[50] GROEN A K,NIEUWDORP M.An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases[J].EMBO Mol Med,2017,9(1):1-3.
[51] BOJANOVA D P,BORDENSTEIN S R.Fecal transplants:what is being transferred?[J].PLoS Biol,2016, 14(7):e1002503.
[52] FUENTES S,VAN NOOD E,TIMS S,et al.Reset of a critically disturbed microbial ecosystem:faecal transplant in recurrent Clostridium difficile infection[J].ISME J,2014,8(8):1621-1633.
[53] GUPTA S,ALLEN-VERCOE E,PETROF E O.Fecal microbiota transplantation:in perspective[J].Ther Adv Gastroenterol,2016,9(2):229-239.
[54] ANDREWS P J,BORODY T J."Putting back the bugs":bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome[J].Med J Aust,1993,159(9):633-634.
[55] VRIEZE A,VAN N E,HOLLEMAN F,et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J].Gastroenterology,2012,143(4):913-916.
[56] BROECKER F,KLUMPP J,SCHUPPLER M,et al.Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation[J].Cold Spring Harb Mol Case Stud,2016,2(1):a000448.
[57] CHEHOUD C,DRYGA A,HWANG Y,et al.Transfer of viral communities between human individuals during fecal microbiota transplantation[J].mBio,2016,7(2):e00322.
[58] OTT S J,WAETZIG G H,REHMAN A,et al.Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection[J].Gastroenterology,2017,152(4):799-811.
[59] ZUO T,WONG S H,LAM K,et al.Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome[J].Gut,2017,67(4):634-643.
[60] ESTEVE E,RICART W,FERNÁNDEZ-REAL J M.Gut microbiota interactions with obesity,insulin resistance and type 2 diabetes:did gut microbiote co-evolve with insulin resistance?[J].Curr Opin Clin Nutr Metab Care,2011,14(5):483-490.
[61] MA Y F,YOU X Y,MAI G Q,et al.A human gut phage catalog correlates the gut phageome with type 2 diabetes[J].Microbiome,2018,6(1):24.
[62] ZHAO G Y,VATANEN T,DROIT L,et al.Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children[J].Proc Natl Acad Sci U S A,2017,114(30):E6166-E6175.
[63] KOSTIC A D,GEVERS D,SILJANDER H,et al.The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes[J].Cell Host Microbe,2015,17(2):260-273. |